Sol-Gel Technologies, Ltd.

Home » Sol-Gel Technologies, Ltd.

IPO

Sol-Gel Technologies, Ltd.

They are a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases

Symbol

SLGL

Price Range
TBD

Anticipated Shares
6,250,000

Effective Date
February 1, 2018

Underwriters
Jefferies, BMO Capital Markets

To view the prospectus for Sol-Gel Technologies, Ltd. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253